PL374463A1 - Modulacja funkcji receptorów LIR celem leczenia przewlekłego postępującego gośćca stawowego - Google Patents

Modulacja funkcji receptorów LIR celem leczenia przewlekłego postępującego gośćca stawowego

Info

Publication number
PL374463A1
PL374463A1 PL02374463A PL37446302A PL374463A1 PL 374463 A1 PL374463 A1 PL 374463A1 PL 02374463 A PL02374463 A PL 02374463A PL 37446302 A PL37446302 A PL 37446302A PL 374463 A1 PL374463 A1 PL 374463A1
Authority
PL
Poland
Prior art keywords
modulation
rheumatoid arthritis
treat rheumatoid
lir
function
Prior art date
Application number
PL02374463A
Other languages
English (en)
Inventor
Jonathan P. Arm
Nicodemus Tedla
Luis G. Borges
Original Assignee
Immunex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corporation filed Critical Immunex Corporation
Publication of PL374463A1 publication Critical patent/PL374463A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL02374463A 2001-11-14 2002-11-12 Modulacja funkcji receptorów LIR celem leczenia przewlekłego postępującego gośćca stawowego PL374463A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33589901P 2001-11-14 2001-11-14

Publications (1)

Publication Number Publication Date
PL374463A1 true PL374463A1 (pl) 2005-10-17

Family

ID=30770813

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02374463A PL374463A1 (pl) 2001-11-14 2002-11-12 Modulacja funkcji receptorów LIR celem leczenia przewlekłego postępującego gośćca stawowego

Country Status (8)

Country Link
US (1) US20050238643A1 (pl)
EP (1) EP1453540A4 (pl)
JP (1) JP2005532256A (pl)
AU (1) AU2002360376B2 (pl)
CA (1) CA2466118A1 (pl)
MX (1) MXPA04004491A (pl)
PL (1) PL374463A1 (pl)
WO (1) WO2003041650A2 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2589808A1 (en) * 2004-11-02 2006-05-11 Dainippon Sumitomo Pharma Co., Ltd. Combination drug for treating autoimmune disease
GB0510627D0 (en) 2005-05-25 2005-06-29 Avidex Ltd Polypeptides
EP1907001B1 (en) 2005-06-17 2015-07-15 Merck Sharp & Dohme Corp. Ilt3 binding molecules and uses therefor
CA2655903A1 (en) 2006-06-19 2008-08-07 Tolerx, Inc. Ilt3 binding molecules and uses therefor
WO2009140361A1 (en) * 2008-05-13 2009-11-19 Genentech, Inc. ANTI-PirB ANTIBODIES
JP5637981B2 (ja) * 2009-03-03 2014-12-10 国立大学法人北海道大学 関節リウマチまたはその関連疾患の予防または治療剤
WO2011091181A1 (en) 2010-01-20 2011-07-28 Tolerx, Inc. Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments
CA2787783A1 (en) * 2010-01-20 2011-07-28 Tolerx, Inc. Anti-ilt5 antibodies and ilt5-binding antibody fragments
US9238018B2 (en) * 2012-11-20 2016-01-19 Revive Therapeutics Inc. Use of bucillamine in the treatment of gout
TWI796329B (zh) 2017-04-07 2023-03-21 美商默沙東有限責任公司 抗－ilt4抗體及抗原結合片段
EA202091540A1 (ru) 2017-12-22 2021-03-22 Джаунс Терапьютикс, Инк. Антитела к lilrb2
CN113056483B (zh) 2018-07-09 2025-08-01 戊瑞治疗有限公司 结合到ilt4的抗体
BR112022015832A2 (pt) * 2020-02-12 2022-10-25 Bioinvent Int Ab Molécula de anticorpo, sequência de nucleotídeos isolada, plasmídeo, célula, uso de uma molécula de anticorpo, composição farmacêutica, e, método para tratamento de rejeição de enxerto, um distúrbio autoimune e/ou um distúrbio inflamatório
MY209480A (en) 2020-05-01 2025-07-11 Ngm Biopharmaceuticals Inc Ilt-binding agents and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5927398A (en) * 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Fc receptors and polypeptides
US6384203B1 (en) * 1999-05-12 2002-05-07 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
US6448035B1 (en) * 1997-04-24 2002-09-10 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)
WO2001055335A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides

Also Published As

Publication number Publication date
AU2002360376B2 (en) 2006-05-18
US20050238643A1 (en) 2005-10-27
JP2005532256A (ja) 2005-10-27
CA2466118A1 (en) 2003-05-22
WO2003041650A3 (en) 2004-01-29
EP1453540A4 (en) 2005-06-01
EP1453540A2 (en) 2004-09-08
MXPA04004491A (es) 2005-05-16
WO2003041650A2 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
GB2393202B (en) Methods of well treatment
HUS1000008I1 (hu) Oldható CTLA4 molekulák alkalmazása reumatoid artritisz kezelésére
EP1443929A4 (en) TREATMENT OF CNS DISTURBANCES WITH CNS TARGET MODULATORS
PL374463A1 (pl) Modulacja funkcji receptorów LIR celem leczenia przewlekłego postępującego gośćca stawowego
GB2391015B (en) Treatment of hydrocarbons containing sulfides
GB0109087D0 (en) Treatment of suspensions
AU2003288901A8 (en) Treatment of rheumatoid arthritis by inhibition of pde4
AU2002366788A8 (en) Antisense modulation of ship-1 expression
AU2003297897A8 (en) Modulation of stat 6 expression
GB0124124D0 (en) Methods of treatment
IL162736A0 (en) Methods of inducing or enhancing connective tissuerepair
GB0220714D0 (en) Dewatering of suspensions
GB0113910D0 (en) Treatment of liquids
EP1434593A4 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
IL174242A0 (en) Treatment of rheumatoid arthritis with cd99 antagonists
EP1450849A4 (en) METHOD FOR TREATING ENDOMETREOSE
GB0117728D0 (en) Processing of hydrocarbons
GB0113514D0 (en) Sludge processor
TW493722U (en) Improved structure of lampwick
GB0126436D0 (en) Detection of predispostion to osteoporosis
GB0002772D0 (en) Treatment of rheumatoid arthritis
PL367941A1 (pl) Leczenie lipodystrofii
GB0208630D0 (en) Treatment of rheumatoid arthritis
AU2003259028A8 (en) Combinations for the treatment of rheumatoid arthritis
HU0104370D0 (en) Honeyed schnaps of oerseg

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)